Invention Grant
US09096579B2 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
有权
氨基 - 吲哚基取代的咪唑基 - 嘧啶及其作为药物的用途
- Patent Title: Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
- Patent Title (中): 氨基 - 吲哚基取代的咪唑基 - 嘧啶及其作为药物的用途
-
Application No.: US13864394Application Date: 2013-04-17
-
Publication No.: US09096579B2Publication Date: 2015-08-04
- Inventor: Georg Dahmann , Horst Dollinger , Christian Gnamm , Dennis Fiegen , Matthias Hoffmann , Jasna Klicic , David James Lamb , Andreas Schnapp
- Applicant: Georg Dahmann , Horst Dollinger , Christian Gnamm , Dennis Fiegen , Matthias Hoffmann , Jasna Klicic , David James Lamb , Andreas Schnapp
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Wendy A. Petka; Usha R. Patel
- Priority: EP12164861 20120420
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/551 ; A61K31/553 ; A61K31/5386 ; A61K31/5377 ; A61K31/541 ; A61K31/55 ; C07D498/10 ; C07D209/42 ; C07D403/06 ; C07D487/04 ; C07D409/14 ; C07D403/14 ; C07D405/14 ; C07D401/14 ; C07D413/14 ; A61K45/06 ; C07D417/14 ; C07D471/04 ; C07D487/10 ; C07D498/04 ; C07D513/04
Abstract:
The invention relates to new amino-indole-substituted imidazolyl-pyrimidines of formula 1 wherein R1, R2, R3, R4 and R5 are defined as in claim 1 and pharmaceutically acceptable salts thereof and the use of these compounds for the preparation of a medicament for treating a disease selected from asthma, COPD, rheumatoid arthritis, specific lymphomas and specific diseases of the nervous system.
Public/Granted literature
- US20130281430A1 Amino-Indolyl-Substituted Imidazolyl-Pyrimidines and Their Use as Medicaments Public/Granted day:2013-10-24
Information query
IPC分类:
